3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy.
about
Chinese Herbs Interfering with Cancer Reprogramming MetabolismThe sweet trap in tumors: aerobic glycolysis and potential targets for therapyAdipose tissue dysfunction and its effects on tumor metabolismIntracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cellsComprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastomaHexokinase II-derived cell-penetrating peptide targets mitochondria and triggers apoptosis in cancer cellsEvolutionary dynamics of carcinogenesis and why targeted therapy does not work.Anticancer targets in the glycolytic metabolism of tumors: a comprehensive reviewMetabolic engineering and classical selection of the methylotrophic thermotolerant yeast Hansenula polymorpha for improvement of high-temperature xylose alcoholic fermentation.Endoplasmic reticulum stress mediates the anti-inflammatory effect of ethyl pyruvate in endothelial cellsLarge-scale identification and analysis of suppressive drug interactions.Systemic administration of 3-bromopyruvate reveals its interaction with serum proteins in a rat model.3-Bromopyruvate inhibits human gastric cancer tumor growth in nude mice via the inhibition of glycolysis.Science to practice: Which approaches to combination interventional oncologic therapy hold the greatest promise of obtaining maximal clinical benefit?Science to practice: what do molecular biologic studies in rodent models add to our understanding of interventional oncologic procedures including percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists?Therapeutic targeting of cancer cell metabolism.Mechanisms underlying 3-bromopyruvate-induced cell death in colon cancerEPR oxygen imaging and hyperpolarized 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvateAnticancer agents that counteract tumor glycolysis.Mitochondrial permeability transition pore as a selective target for anti-cancer therapyChanging the energy of an immune responseRegulation of the proliferation of colon cancer cells by compounds that affect glycolysis, including 3-bromopyruvate, 2-deoxyglucose and biguanides.A causal link from ALK to hexokinase II overexpression and hyperactive glycolysis in EML4-ALK-positive lung cancerMn porphyrin regulation of aerobic glycolysis: implications on the activation of diabetogenic immune cellsRelationship between Porcine Sperm Motility and Sperm Enzymatic Activity using Paper-based Devices.Novel ways to target brain tumour metabolism.MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.Mitochondrial metabolism inhibitors for cancer therapy.3-Bromopyruvate: targets and outcomes.Glyceraldehyde-3-phosphate dehydrogenase: a promising target for molecular therapy in hepatocellular carcinomaTargeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy.Tumor glycolysis as a target for cancer therapy: progress and prospects.GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity.The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?Deregulation of energy metabolism promotes antifibrotic effects in human hepatic stellate cells and prevents liver fibrosis in a mouse model.The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside.Identification and Optimization of Combinatorial Glucose Metabolism Inhibitors in Hepatocellular Carcinomas.Energy metabolism targeted drugs synergize with photodynamic therapy to potentiate breast cancer cell death.Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation.Combination studies of platinum(II)-based metallointercalators with buthionine-S,R-sulfoximine, 3-bromopyruvate, cisplatin or carboplatin.
P2860
Q26744552-2CEBC5EB-CC34-4E1D-B150-03BF5C52CF90Q26766079-905B9F57-66F6-4F2A-AFBC-DB0A26299A3FQ28080748-F72647C2-CB8A-441B-8AA3-E5A0EF76400EQ28395875-4A6A940C-54D0-43C6-883E-E595E3813648Q28546923-F43BBA50-3AEC-49AC-BDF4-713A69C4E00CQ33554640-53621A0E-4A57-4C0E-9BBF-1F9A2FC0E823Q34005286-549ED54A-369A-40D0-86F6-9E42CFDDF05DQ34028478-0F24870F-D20A-4EE8-9669-861FC405A609Q34091389-94E321EF-B988-4718-8DBC-B5DC27D48DA7Q34626458-1559A3B6-7F3F-4FF9-9807-B54E634F56F9Q34799147-763E025F-A9BA-4D40-A862-06F48E051513Q34834980-44FDCFEE-E133-48F7-9895-95C77D4EE8E9Q34993713-F641904A-CCBF-42B4-A495-6D86266FD9D1Q35560995-502C9C9D-BF6D-4AB0-85E1-45D3110F263FQ35773556-F7DE082C-BE5B-4698-B7AB-0DE21023E5D1Q35936525-7EC98E57-1563-4F9D-B9A6-EA0D1482A1F2Q35987880-A16685E7-5364-47B8-8193-DAA918C5FA06Q36342034-A7B8D3DB-94DD-4D3A-9DD5-AF391B082558Q36452381-352CF263-AD92-4B28-9922-5BB85427F89EQ36668047-381643BD-45F8-47F1-8156-4AC4C040D348Q37021691-F242E284-9038-4516-966D-6834A6F987E4Q37247546-9C6C18A7-8FD7-4670-AE93-8F27ED1DE54DQ37389418-94773BBC-803D-48B3-A6E0-435C62D23730Q37597126-EE603124-99BD-43F5-939D-3F77F390EF9AQ37741295-B3E5C224-EF17-45D4-B773-D9FC73440379Q37884056-210745BC-91CE-457E-8684-C67F5DD42B41Q37906482-6B03A015-6905-4A38-9BE7-9785C324A083Q37932441-CCCF6D24-CE7E-4EC5-BC3F-C46BDDDA807EQ37980697-DA1F6EB9-C77A-46F2-AA2B-8A23A772FCCAQ38042261-BB0A7BA8-705D-443F-A987-836BED535F69Q38132274-6AA0B85B-7979-42DD-971F-C5A887CF3FBDQ38168262-1EA4F0F5-3C11-419C-A8DC-D928B2A25154Q38197021-FB84980D-AF18-4F7A-9B3A-B06AA795FB57Q38612793-64F5D7D7-DD1A-4A7D-A599-7B58D5FA66DBQ38822836-E5D42573-B4AF-46F9-84CB-CB4C470E5ED8Q38837920-F4D47BCF-5653-4DFE-B395-37A97C66FBF4Q38893018-D05AF5E1-BA4F-4FAE-8111-E18590C6B8C5Q38943330-2558FCCC-94C0-4F1B-9D2F-E7A096DB9A07Q38959435-037028E3-45EA-4D43-82C8-D6965B6C89D1Q39089137-D7E4794F-014A-4AC6-989F-EBD202C5E6C8
P2860
3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy.
@en
3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy.
@nl
type
label
3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy.
@en
3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy.
@nl
prefLabel
3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy.
@en
3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy.
@nl
P2093
P1476
3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy.
@en
P2093
Ganapathy-Kanniappan S
Geschwind JF
Kunjithapatham R
P304
P356
10.2174/138920110791591427
P577
2010-08-01T00:00:00Z